CN101830837A - 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法 - Google Patents

合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法 Download PDF

Info

Publication number
CN101830837A
CN101830837A CN201010200760A CN201010200760A CN101830837A CN 101830837 A CN101830837 A CN 101830837A CN 201010200760 A CN201010200760 A CN 201010200760A CN 201010200760 A CN201010200760 A CN 201010200760A CN 101830837 A CN101830837 A CN 101830837A
Authority
CN
China
Prior art keywords
mixture
compounds
formula
water
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010200760A
Other languages
English (en)
Chinese (zh)
Inventor
罗纳德·S·米夏拉克
马哈茂德·莱文特
弗雷德里克·J·维维尔伯格
阿拉·R·博亚简
帕诺利尔·拉夫恩德拉纳特
米歇尔·康坦
艾伦·斯托克顿
迈克尔·W·温克利
穆斯米·高希
克里斯托夫·德恩哈特
查尔斯·吉诺斯欧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of CN101830837A publication Critical patent/CN101830837A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201010200760A 2004-08-19 2005-08-18 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法 Pending CN101830837A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60312404P 2004-08-19 2004-08-19
US60/603,124 2004-08-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2005800280209A Division CN101006048B (zh) 2004-08-19 2005-08-18 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法

Publications (1)

Publication Number Publication Date
CN101830837A true CN101830837A (zh) 2010-09-15

Family

ID=35219553

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201010200760A Pending CN101830837A (zh) 2004-08-19 2005-08-18 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法
CN2005800280209A Expired - Fee Related CN101006048B (zh) 2004-08-19 2005-08-18 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2005800280209A Expired - Fee Related CN101006048B (zh) 2004-08-19 2005-08-18 合成适用作cpla2抑制剂的c-2、c-3取代的n-烷基化吲哚的方法

Country Status (24)

Country Link
US (3) US7582772B2 (cg-RX-API-DMAC7.html)
EP (1) EP1778629B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008510707A (cg-RX-API-DMAC7.html)
KR (1) KR20070043036A (cg-RX-API-DMAC7.html)
CN (2) CN101830837A (cg-RX-API-DMAC7.html)
AR (1) AR053410A1 (cg-RX-API-DMAC7.html)
AT (1) ATE517084T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005277392A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514431A (cg-RX-API-DMAC7.html)
CA (1) CA2576008A1 (cg-RX-API-DMAC7.html)
CR (1) CR8936A (cg-RX-API-DMAC7.html)
EC (1) ECSP077244A (cg-RX-API-DMAC7.html)
GT (1) GT200500224A (cg-RX-API-DMAC7.html)
HN (1) HN2005000474A (cg-RX-API-DMAC7.html)
IL (1) IL181364A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007002042A (cg-RX-API-DMAC7.html)
NO (1) NO20071253L (cg-RX-API-DMAC7.html)
PE (1) PE20060628A1 (cg-RX-API-DMAC7.html)
RU (1) RU2401829C2 (cg-RX-API-DMAC7.html)
SG (1) SG155214A1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002200A (cg-RX-API-DMAC7.html)
TW (1) TW200609214A (cg-RX-API-DMAC7.html)
UA (1) UA85428C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006023611A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
WO2008055148A2 (en) * 2006-10-31 2008-05-08 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
CL2007003143A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composicion farmaceutica que comprende un compuesto derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 5-50% de un segundo solubilizante, 10-30% de un primer diluyente y 1-15% de un segundo diluyente; proceso de prepracion; y forma de dosificacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
UA81596C2 (en) * 1999-12-09 2008-01-25 Авентис Кропсаенс Гмбх Nitro-sulfobenzamides
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
HUP0402577A3 (en) * 2001-12-03 2011-05-30 Wyeth Corp Indole derivatives as inhibitors of cytosolic phospholipase a2, process for producing them and pharmaceutical compositions containing them
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
WO2005012235A1 (en) 2003-07-29 2005-02-10 Ciba Specialty Chemicals Holding Inc. 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
CN101006048B (zh) 2011-07-06
ECSP077244A (es) 2007-03-29
KR20070043036A (ko) 2007-04-24
JP2008510707A (ja) 2008-04-10
HN2005000474A (es) 2009-04-07
AR053410A1 (es) 2007-05-09
US20060041005A1 (en) 2006-02-23
TW200609214A (en) 2006-03-16
NO20071253L (no) 2007-05-15
AU2005277392A1 (en) 2006-03-02
CN101006048A (zh) 2007-07-25
US8034960B2 (en) 2011-10-11
GT200500224A (es) 2006-03-21
EP1778629B1 (en) 2011-07-20
RU2401829C2 (ru) 2010-10-20
US7582772B2 (en) 2009-09-01
SG155214A1 (en) 2009-09-30
US20090306428A1 (en) 2009-12-10
ATE517084T1 (de) 2011-08-15
US7842837B2 (en) 2010-11-30
EP1778629A1 (en) 2007-05-02
PE20060628A1 (es) 2006-08-14
US20110054189A1 (en) 2011-03-03
UA85428C2 (ru) 2009-01-26
SV2006002200A (es) 2006-05-09
BRPI0514431A (pt) 2008-06-10
CR8936A (es) 2007-04-26
RU2007105231A (ru) 2008-09-27
IL181364A0 (en) 2007-07-04
CA2576008A1 (en) 2006-03-02
MX2007002042A (es) 2007-03-29
WO2006023611A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
CN101048376B (zh) 二氢吲哚化合物及其生产方法
CN102079743B (zh) 二肽基肽酶抑制剂
ES2226996T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
US7842837B2 (en) Process for the synthesis of C-2, C-3 substituted N-alkylated indoles useful as cPLA2 inhibitors
EP1776347B1 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
EP0380144B1 (en) Process for producing optically active benzene-sulfonamide derivatives
NO167283B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-indolyletylsulfonsyreamider.
CA2268418A1 (en) .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors
KR101514593B1 (ko) 5-(메틸-1h-이미다졸-1-일)-3-(트리플루오로메틸)-벤젠아민의 합성 방법
CN100577640C (zh) 制备cpla2抑制剂的方法
CZ291802B6 (cs) Způsob výroby (R)-(-)-5-[2-[2-(2-ethoxyfenoxy)ethylamino]propyl]-2-methoxybenzensulfonamidu
JP2008510707A5 (cg-RX-API-DMAC7.html)
US7375248B2 (en) Inhibitors of matrix metalloproteinase
KR20070045346A (ko) 4-아미노 치환-2-치환-1,2,3,4-테트라하이드로퀴놀린화합물
CN1429204A (zh) 制备联苯化合物的方法
CN101184748B (zh) 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)苯胺的方法
KR101170024B1 (ko) 아조세미드 제조방법
WO1994006753A1 (fr) Procede de production d'un derive d'aniline
US7329780B2 (en) Method of preparing optically pure phenethylamine derivatives
TW201335109A (zh) 光學活性化合物之製造方法
JPH02200664A (ja) スルホニウム化合物の製法
CN101538229A (zh) 一种抗良性前列腺肥大药物坦索罗辛之合成方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100915